Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the BioXcel Therapeutics, Inc. 2020 Incentive Award Plan and the BioXcel Therapeutics, Inc. 2020 Employee Stock Purchase Plan of our report dated March 15, 2023, with respect to the consolidated financial statements of BioXcel Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP | |
| Stamford, Connecticut | |
| March 15, 2023 | |
